We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.36B
AUM Growth
+$1.41B
Cap. Flow
+$933M
Cap. Flow %
12.67%
Top 10 Hldgs %
19.57%
Holding
818
New
45
Increased
412
Reduced
173
Closed
113

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Healthcare 18.66%
3 Industrials 11.13%
4 Financials 10.9%
5 Consumer Discretionary 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNST icon
126
Renasant Corp
RNST
$4.02B
$14M 0.19%
617,042
+241,645
+64% +$5.81M
WEC icon
127
WEC Energy
WEC
$35.6B
$13.9M 0.19%
143,392
+7,247
+5% +$675K
FOXF icon
128
Fox Factory Holding Corp
FOXF
$785M
$13.6M 0.19%
183,351
+71,103
+63% +$6.4M
GWRE icon
129
Guidewire Software
GWRE
$13.1B
$13.6M 0.18%
130,039
-362,197
-74% -$40.7M
GMED icon
130
Globus Medical
GMED
$11.1B
$13.5M 0.18%
272,502
+117,555
+76% +$6.06M
CHDN icon
131
Churchill Downs
CHDN
$5.82B
$13.4M 0.18%
163,778
+72,986
+80% +$5.66M
FLIR
132
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$13.1M 0.18%
364,540
+14,808
+4% +$564K
MCD icon
133
McDonald's
MCD
$188B
$12.9M 0.18%
58,710
+967
+2% +$199K
NJR icon
134
New Jersey Resources
NJR
$5.86B
$12.7M 0.17%
471,169
+236,369
+101% +$7.2M
TXNM
135
TXNM Energy Inc
TXNM
$5.94B
$12.7M 0.17%
306,550
+98,759
+48% +$4.12M
PODD icon
136
Insulet
PODD
$11.8B
$12.6M 0.17%
53,221
+4,123
+8% +$868K
BFAM icon
137
Bright Horizons
BFAM
$4.01B
$12.5M 0.17%
81,947
+64,934
+382% +$8.17M
HZNP
138
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$12.4M 0.17%
160,178
+37,432
+30% +$2.58M
MLM icon
139
Martin Marietta Materials
MLM
$32.6B
$12.3M 0.17%
52,283
+2,055
+4% +$445K
DAVA icon
140
Endava
DAVA
$163M
$12.1M 0.16%
192,172
+170,972
+806% +$9.26M
CIR
141
DELISTED
CIRCOR International, Inc
CIR
$11.8M 0.16%
432,081
+100,244
+30% +$2.79M
BIO icon
142
Bio-Rad Laboratories Class A
BIO
$8.96B
$11.8M 0.16%
22,855
+2,606
+13% +$1.32M
WMT icon
143
Walmart Inc
WMT
$881B
$11.8M 0.16%
252,033
-11,655
-4% -$518K
MRK icon
144
Merck
MRK
$316B
$11.6M 0.16%
147,156
-9,627
-6% -$754K
EFSC icon
145
Enterprise Financial Services Corp
EFSC
$2.42B
$11.6M 0.16%
425,116
+164,475
+63% +$4.87M
HAE icon
146
Haemonetics
HAE
$3.94B
$11.6M 0.16%
132,658
+88,719
+202% +$7.75M
NBL
147
DELISTED
Noble Energy, Inc.
NBL
$11.6M 0.16%
1,352,633
-49,124
-4% -$480K
RP
148
DELISTED
RealPage, Inc.
RP
$11.5M 0.16%
199,608
+61,768
+45% +$3.82M
APH icon
149
Amphenol
APH
$201B
$11.5M 0.16%
423,664
+1,828
+0.4% +$48.2K
AL
150
DELISTED
Air Lease Corp
AL
$11.5M 0.16%
389,352
-357,656
-48% -$10.5M

Similar funds

Segall Bryant & Hamill's Q3 2020 Portfolio in Review

As of Q3 2020, Segall Bryant & Hamill held 818 positions worth $7.36B, up 24% from $5.95B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Segall Bryant & Hamill deployed $933M of net new capital in Q3 2020, opening 45 new positions and adding to 412 existing holdings. Its largest new stake was Tapestry: 966,818 shares worth $15.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Guidewire Software, an estimated $40.7M trimmed.

  • Segall Bryant & Hamill's largest Q3 2020 buy was Tapestry: 966,818 shares worth $15.1M.
  • Segall Bryant & Hamill added most to Keysight in Q3 2020, an estimated $45.2M increase.
  • Segall Bryant & Hamill's biggest Q3 2020 reduction was Guidewire Software, cutting an estimated $40.7M.
  • Segall Bryant & Hamill fully exited Mandiant, Inc. Common Stock in Q3 2020, selling an estimated $8.79M.
  • Segall Bryant & Hamill's ten largest holdings make up 20% of its $7.36B portfolio in Q3 2020.
  • Segall Bryant & Hamill opened 45 new positions and closed 113 in Q3 2020.
  • Segall Bryant & Hamill's portfolio value rose 24% quarter-over-quarter to $7.36B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2020, filed 13 Nov 2020.